Although numerical increases in the primary endpoints of PFS and/or OS were seen in KEYNOTE‐361 and DANUBE, they did not reach statistical significance [ 39 , 40 ].
← all excerpts
The Rapidly Evolving Landscape of First-Line Targeted Therapy in Metastatic Urothelial Cancer: A Systematic Review.
1
—
—